Discover › Program page

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

National Institutes of Health active

Rounds we have recorded

1. Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

   National Institutes of Health Grant ≤ US$150,000

   Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies offering new capabilities for the molecular or cellular...

   Open

   Application 2026-11-10 exact time to be confirmed about 6 days

   Verified: 2026-11-04 · Official page ↗

   ☆ Save